2014 Predicts Data Revelations & Better Usability in the Life Sciences Sector – in our last blog, we revealed how cost pressures are forcing a dramatic reinvention across Life Sciences business models, with many customers using technology innovations to gain efficiencies and contain costs. We also showed how closer partnerships in the sector will make new collaboration models contagious and more prevalent.
Now we add our next two predictions for 2014 and beyond, and continue to welcome your thoughts and comments further below to continue the dialogue.
An Industry of Discoverers
This prediction could be tied back to cost pressures, but we have found our science-heavy industry is inherently also a curious one. We believe the analytical and research-oriented minds in Life Sciences will readily act on big data for big discoveries.
As more data becomes available electronically, and is more broadly shared because of security improvements, more data analysis will occur. New drug candidates may be unveiled, and compelling insights for improving lives may be mined.
The older, “manual” process of discovery will be replaced through the analysis of electronic clinical and patient data combined. This will enable potential drug candidates to be discovered earlier in the drug discovery process, and could reduce the number of failed candidate compounds within the pipeline.
More intelligence will be driven from content that was efficiently digitized, organized, and securely shared (see prediction #1, “efficiency first,” in our initial blog). The inventive minds in our industry will not sit idle amidst these data treasures.
The Rise of the Power User
The final frontier we envision in the Life Science industry transformation will be highly visible across technology solutions: usability.
Legacy systems with cumbersome functionality will give way to more intuitive, user-driven solutions. The elegant appeal of intuitive consumer apps will eventually permeate the mindset of hard-working scientists, chemists, and molecular biologists.
Often numbering in the thousands, Life Sciences system users will push for easy-to-use functionality. And more often than not, mobile access will become the norm, even in their highly regulated situations.
Executives responsible for approving manufacturing processes will want to electronically review and sign on a tablet device, for example. The more common method of going to a PC and physically logging into a system will no longer be acceptable (see “collaboration is contagious” in our first predictions blog).
Personnel on the manufacturing floor will want to leverage tablets to access drug recipes on the shop floor, instead of working from paper copies, or physically walking to a PC across the room. Like any motivated, highly skilled worker, power users will want to get things done in increasingly easy and intuitive ways.